Zkusit zdarma
Akero Therapeutics, Inc.

Akero Therapeutics, Inc.

AKRO
Cena:
$ 54.65
0.00 (0.00%)
Valuace
70
Růst
0
Zdraví
75
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
Bourgeon Capital Management LLC Takes Position in Akero Therapeutics, Inc. $AKRO

Bourgeon Capital Management LLC Takes Position in Akero Therapeutics, Inc. $AKRO

3:47 03-01-2026

Bourgeon Capital Management LLC acquired a new position in shares of Akero Therapeutics, Inc. (NASDA...

Corient Private Wealth LLC Takes $3.93 Million Position in Akero Therapeutics, Inc. $AKRO

Corient Private Wealth LLC Takes $3.93 Million Position in Akero Therapeutics, Inc. $AKRO

3:38 22-12-2025

Corient Private Wealth LLC acquired a new stake in shares of Akero Therapeutics, Inc. (NASDAQ: AKRO)...

Alkeon Capital Management LLC Grows Stake in Akero Therapeutics, Inc. $AKRO

Alkeon Capital Management LLC Grows Stake in Akero Therapeutics, Inc. $AKRO

3:59 13-12-2025

Alkeon Capital Management LLC increased its holdings in Akero Therapeutics, Inc. (NASDAQ: AKRO) by 1...

Novo Nordisk has completed its acquisition of Akero Therapeutics

Novo Nordisk has completed its acquisition of Akero Therapeutics

8:51 09-12-2025

Bagsværd, Denmark and South San Francisco, CA, US, 9 December 2025 – Novo Nordisk and Akero Thera...

Berger Montague PC Investigates Akero Therapeutics, Inc. and Its Board of Directors for Breach of Fiduciary Duties and Violations of Federal Securities Laws (NASDAQ: AKRO)

Berger Montague PC Investigates Akero Therapeutics, Inc. and Its Board of Directors for Breach of Fiduciary Duties and Violations of Federal Securities Laws (NASDAQ: AKRO)

13:22 12-11-2025

PHILADELPHIA , Nov. 12, 2025 /PRNewswire/ --  Berger Montague PC  advises shareholders of Akero T...

Akero Therapeutics Presents New Analyses from Phase 2b SYMMETRY and HARMONY Trials of Efruxifermin at 76th Annual AASLD The Liver Meeting® 2025

Akero Therapeutics Presents New Analyses from Phase 2b SYMMETRY and HARMONY Trials of Efruxifermin at 76th Annual AASLD The Liver Meeting® 2025

7:00 07-11-2025

Post-hoc analyses corroborate previously reported antifibrotic effects of efruxifermin observed in 9...

Berger Montague PC Investigates Akero Therapeutics, Inc. and Its Board of Directors for Breach of Fiduciary Duties and Violations of Federal Securities Laws (NASDAQ: AKRO)

Berger Montague PC Investigates Akero Therapeutics, Inc. and Its Board of Directors for Breach of Fiduciary Duties and Violations of Federal Securities Laws (NASDAQ: AKRO)

16:41 04-11-2025

PHILADELPHIA , Nov. 4, 2025 /PRNewswire/ --  Berger Montague PC  advises shareholders of Akero Th...

Berger Montague PC Investigates Akero Therapeutics, Inc. and Its Board of Directors for Breach of Fiduciary Duties and Violations of Federal Securities Laws (NASDAQ: AKRO)

Berger Montague PC Investigates Akero Therapeutics, Inc. and Its Board of Directors for Breach of Fiduciary Duties and Violations of Federal Securities Laws (NASDAQ: AKRO)

18:06 29-10-2025

PHILADELPHIA , Oct. 29, 2025 /PRNewswire/ --  Berger Montague PC advises shareholders of Akero The...

Akero Therapeutics, Inc. (NASDAQ:AKRO) Receives Consensus Recommendation of “Hold” from Analysts

Akero Therapeutics, Inc. (NASDAQ:AKRO) Receives Consensus Recommendation of “Hold” from Analysts

1:32 22-10-2025

Shares of Akero Therapeutics, Inc. (NASDAQ: AKRO - Get Free Report) have earned an average recommend...

My Top 3 Pharma Stocks

My Top 3 Pharma Stocks

11:38 20-10-2025

Obesity, type 2 diabetes, and cancer continue to grow across the globe, but pharma stocks remain off...

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Akero Therapeutics, Inc. (NASDAQ: AKRO)

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Akero Therapeutics, Inc. (NASDAQ: AKRO)

17:30 10-10-2025

NEW YORK, Oct. 10, 2025 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & ...

Why Akero Therapeutics Stock Trounced the Market on Thursday

Why Akero Therapeutics Stock Trounced the Market on Thursday

16:48 09-10-2025

One of the best catalysts for sudden, sharp rise in the price of a stock is when the company behind ...

Shareholder Alert: The Ademi Firm investigates whether Akero Therapeutics Inc. is obtaining a Fair Price for its Public Shareholders

Shareholder Alert: The Ademi Firm investigates whether Akero Therapeutics Inc. is obtaining a Fair Price for its Public Shareholders

11:00 09-10-2025

MILWAUKEE , Oct. 9, 2025 /PRNewswire/ -- The Ademi Firm is investigating Akero (NASDAQ: AKRO) for p...

Novo Nordisk to acquire Akero Therapeutics for its experimental liver disease drug

Novo Nordisk to acquire Akero Therapeutics for its experimental liver disease drug

10:21 09-10-2025

Novo Nordisk said on Thursday it would buy U.S.-based Akero Therapeutics for up to $5.2 billion to a...

AKRO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Akero Therapeutics, Inc. Is Fair to Shareholders

AKRO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Akero Therapeutics, Inc. Is Fair to Shareholders

8:00 09-10-2025

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether t...

Akero Therapeutics Stock Soars on Novo Nordisk Deal.

Akero Therapeutics Stock Soars on Novo Nordisk Deal.

7:31 09-10-2025

Novo said it would buy Akero for $54 a share in cash and an additional $6 if it gets U.S. approval o...

Novo Nordisk To Buy Akero Therapeutics for $4.7 Billion

Novo Nordisk To Buy Akero Therapeutics for $4.7 Billion

6:39 09-10-2025

Novo said the acquisition of would contribute to its strategy to develop medicines for people living...

Novo Nordisk buys Akero Therapeutics in the US

Novo Nordisk buys Akero Therapeutics in the US

6:09 09-10-2025

Danish drugmaker Novo Nordisk said on Thursday it had agreed to buy United States based Akero Therap...

Akero Therapeutics to be Acquired by Novo Nordisk for up to $5.2 Billion

Akero Therapeutics to be Acquired by Novo Nordisk for up to $5.2 Billion

6:01 09-10-2025

Shareholders to Receive $54 Per Share in Cash and CVR of $6 Per Share  Advances Akero's Mission of ...

Akero Therapeutics to Present New Data from the Phase 2b SYMMETRY and HARMONY Studies of Efruxifermin at the 76th Annual AASLD The Liver Meeting® 2025

Akero Therapeutics to Present New Data from the Phase 2b SYMMETRY and HARMONY Studies of Efruxifermin at the 76th Annual AASLD The Liver Meeting® 2025

7:00 07-10-2025

SOUTH SAN FRANCISCO, Calif., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKR...

close

NOVO NORDISK HAS COMPLETED ITS ACQUISITION OF AKERO THERAPEUTICS

09-12-2025
BAGSVÆRD, DENMARK AND SOUTH SAN FRANCISCO, CA, US, 9 DECEMBER 2025 – NOVO NORDISK AND AKERO THERA...
Více zde

AKERO THERAPEUTICS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: KAHN SWICK & FOTI, LLC INVESTIGATES ADEQUACY OF PRICE AND PROCESS IN PROPOSED SALE OF AKERO THERAPEUTICS, INC. - AKRO

20-11-2025
NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--FORMER ATTORNEY GENERAL OF LOUISIANA CHARLES C. FOTI, ...
Více zde

BERGER MONTAGUE PC INVESTIGATES AKERO THERAPEUTICS, INC. AND ITS BOARD OF DIRECTORS FOR BREACH OF FIDUCIARY DUTIES AND VIOLATIONS OF FEDERAL SECURITIES LAWS (NASDAQ: AKRO)

12-11-2025
PHILADELPHIA , NOV. 12, 2025 /PRNEWSWIRE/ --  BERGER MONTAGUE PC  ADVISES SHAREHOLDERS OF AKERO T...
Více zde

AKERO THERAPEUTICS PRESENTS NEW ANALYSES FROM PHASE 2B SYMMETRY AND HARMONY TRIALS OF EFRUXIFERMIN AT 76TH ANNUAL AASLD THE LIVER MEETING® 2025

07-11-2025
POST-HOC ANALYSES CORROBORATE PREVIOUSLY REPORTED ANTIFIBROTIC EFFECTS OF EFRUXIFERMIN OBSERVED IN 9...
Více zde

BERGER MONTAGUE PC INVESTIGATES AKERO THERAPEUTICS, INC. AND ITS BOARD OF DIRECTORS FOR BREACH OF FIDUCIARY DUTIES AND VIOLATIONS OF FEDERAL SECURITIES LAWS (NASDAQ: AKRO)

04-11-2025
PHILADELPHIA , NOV. 4, 2025 /PRNEWSWIRE/ --  BERGER MONTAGUE PC  ADVISES SHAREHOLDERS OF AKERO TH...
Více zde

BERGER MONTAGUE PC INVESTIGATES AKERO THERAPEUTICS, INC. AND ITS BOARD OF DIRECTORS FOR BREACH OF FIDUCIARY DUTIES AND VIOLATIONS OF FEDERAL SECURITIES LAWS (NASDAQ: AKRO)

29-10-2025
PHILADELPHIA , OCT. 29, 2025 /PRNEWSWIRE/ --  BERGER MONTAGUE PC ADVISES SHAREHOLDERS OF AKERO THE...
Více zde

AKERO THERAPEUTICS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: KAHN SWICK & FOTI, LLC INVESTIGATES ADEQUACY OF PRICE AND PROCESS IN PROPOSED SALE OF AKERO THERAPEUTICS, INC. - AKRO

10-10-2025
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--FORMER ATTORNEY GENERAL OF LOUISIANA CHARLES C. FOTI, JR., ...
Více zde

$HAREHOLDER ALERT: THE M&A CLASS ACTION FIRM ANNOUNCES AN INVESTIGATION OF AKERO THERAPEUTICS, INC. (NASDAQ: AKRO)

10-10-2025
NEW YORK, OCT. 10, 2025 (GLOBE NEWSWIRE) -- CLASS ACTION ATTORNEY JUAN MONTEVERDE WITH MONTEVERDE & ...
Více zde

SHAREHOLDER ALERT: THE ADEMI FIRM INVESTIGATES WHETHER AKERO THERAPEUTICS INC. IS OBTAINING A FAIR PRICE FOR ITS PUBLIC SHAREHOLDERS

09-10-2025
MILWAUKEE , OCT. 9, 2025 /PRNEWSWIRE/ -- THE ADEMI FIRM IS INVESTIGATING AKERO (NASDAQ: AKRO) FOR P...
Více zde

AKRO STOCK ALERT: HALPER SADEH LLC IS INVESTIGATING WHETHER THE SALE OF AKERO THERAPEUTICS, INC. IS FAIR TO SHAREHOLDERS

09-10-2025
NEW YORK--(BUSINESS WIRE)--HALPER SADEH LLC, AN INVESTOR RIGHTS LAW FIRM, IS INVESTIGATING WHETHER T...
Více zde

AKERO THERAPEUTICS TO BE ACQUIRED BY NOVO NORDISK FOR UP TO $5.2 BILLION

09-10-2025
SHAREHOLDERS TO RECEIVE $54 PER SHARE IN CASH AND CVR OF $6 PER SHARE  ADVANCES AKERO'S MISSION OF ...
Více zde

NOVO NORDISK TO ACQUIRE AKERO THERAPEUTICS AND ITS PROMISING PHASE 3 FGF21 ANALOGUE TO EXPAND MASH PORTFOLIO

09-10-2025
BAGSVÆRD, DENMARK, 9 OCTOBER, 2025 – NOVO NORDISK TODAY ANNOUNCED THAT IT HAS ENTERED INTO A DEFI...
Více zde

AKERO THERAPEUTICS TO PRESENT NEW DATA FROM THE PHASE 2B SYMMETRY AND HARMONY STUDIES OF EFRUXIFERMIN AT THE 76TH ANNUAL AASLD THE LIVER MEETING® 2025

07-10-2025
SOUTH SAN FRANCISCO, CALIF. , OCT. 07, 2025 (GLOBE NEWSWIRE) -- AKERO THERAPEUTICS, INC. (NASDAQ: AK...
Více zde

AKERO THERAPEUTICS TO PRESENT AT THE MORGAN STANLEY 23RD ANNUAL GLOBAL HEALTHCARE CONFERENCE

28-08-2025
SOUTH SAN FRANCISCO, CALIF., AUG. 28, 2025 (GLOBE NEWSWIRE) -- AKERO THERAPEUTICS, INC. (NASDAQ: A...
Více zde

AKERO THERAPEUTICS ANNOUNCES LANCET PUBLICATION OF THE PHASE 2B HARMONY CLINICAL TRIAL DEMONSTRATING 96 WEEKS TREATMENT WITH EFX REDUCED LIVER FIBROSIS IN PATIENTS WITH PRE-CIRRHOTIC MASH

14-08-2025
RESULTS SUPPORT POTENTIAL OF EFRUXIFERMIN (EFX) TO REDUCE RISK OF FIBROSIS PROGRESSION IN PATIENTS ...
Více zde

AKERO THERAPEUTICS REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

08-08-2025
PUBLISHED RESULTS FROM THE 96-WEEK PHASE 2B SYMMETRY TRIAL IN THE NEW ENGLAND JOURNAL OF MEDICINE TH...
Více zde

BRONSTEIN, GEWIRTZ & GROSSMAN, LLC ENCOURAGES AKERO THERAPEUTICS, INC. (AKRO) SHAREHOLDERS TO INQUIRE ABOUT SECURITIES INVESTIGATION

08-06-2025
NEW YORK CITY, NY / ACCESS NEWSWIRE / JUNE 8, 2025 / BRONSTEIN, GEWIRTZ & GROSSMAN, LLC IS INVESTIGA...
Více zde

BRONSTEIN, GEWIRTZ & GROSSMAN, LLC IS INVESTIGATING AKERO THERAPEUTICS, INC. (AKRO) AND ENCOURAGES SHAREHOLDERS TO CONNECT

05-06-2025
NEW YORK CITY, NY / ACCESS NEWSWIRE / JUNE 5, 2025 / BRONSTEIN, GEWIRTZ & GROSSMAN, LLC IS INVESTIGA...
Více zde

BRONSTEIN, GEWIRTZ & GROSSMAN, LLC INITIATES AN INVESTIGATION INTO ALLEGATIONS AGAINST AKERO THERAPEUTICS, INC. (AKRO) AND ENCOURAGES SHAREHOLDERS TO REACH OUT

03-06-2025
NEW YORK CITY, NY / ACCESS NEWSWIRE / JUNE 3, 2025 / BRONSTEIN, GEWIRTZ & GROSSMAN, LLC IS INVESTIGA...
Více zde

AKERO THERAPEUTICS TO PRESENT AT THE GOLDMAN SACHS 46TH ANNUAL GLOBAL HEALTHCARE CONFERENCE

03-06-2025
SOUTH SAN FRANCISCO, CALIF., JUNE 03, 2025 (GLOBE NEWSWIRE) -- AKERO THERAPEUTICS, INC. (NASDAQ: A...
Více zde

BRONSTEIN, GEWIRTZ & GROSSMAN, LLC ANNOUNCES AN INVESTIGATION AGAINST AKERO THERAPEUTICS, INC. (AKRO) AND ENCOURAGES SHAREHOLDERS TO LEARN MORE ABOUT THE INVESTIGATION

01-06-2025
NEW YORK CITY, NY / ACCESS NEWSWIRE / JUNE 1, 2025 / BRONSTEIN, GEWIRTZ & GROSSMAN, LLC IS INVESTIGA...
Více zde

BRONSTEIN, GEWIRTZ & GROSSMAN, LLC ENCOURAGES AKERO THERAPEUTICS, INC. (AKRO) STOCKHOLDERS TO INQUIRE ABOUT SECURITIES INVESTIGATION

29-05-2025
NEW YORK CITY, NY / ACCESS NEWSWIRE / MAY 29, 2025 / BRONSTEIN, GEWIRTZ & GROSSMAN, LLC IS INVESTIGA...
Více zde

AKERO THERAPEUTICS TO PRESENT AT THE JEFFERIES GLOBAL HEALTHCARE CONFERENCE

28-05-2025
SOUTH SAN FRANCISCO, CALIF., MAY 28, 2025 (GLOBE NEWSWIRE) -- AKERO THERAPEUTICS, INC. (NASDAQ: AK...
Více zde

BRONSTEIN, GEWIRTZ & GROSSMAN, LLC ANNOUNCES AN INVESTIGATION AGAINST AKERO THERAPEUTICS, INC. (AKRO) AND ENCOURAGES INVESTORS TO LEARN MORE ABOUT THE INVESTIGATION

27-05-2025
NEW YORK CITY, NY / ACCESS NEWSWIRE / MAY 27, 2025 / BRONSTEIN, GEWIRTZ & GROSSMAN, LLC IS INVESTIGA...
Více zde

AKERO THERAPEUTICS, INC. (AKRO) INVESTIGATION: BRONSTEIN, GEWIRTZ & GROSSMAN, LLC ENCOURAGES SHAREHOLDERS TO CONTACT THE FIRM TO LEARN MORE ABOUT THE INVESTIGATION

25-05-2025
NEW YORK CITY, NY / ACCESS NEWSWIRE / MAY 25, 2025 / BRONSTEIN, GEWIRTZ & GROSSMAN, LLC IS INVESTIGA...
Více zde

BRONSTEIN, GEWIRTZ & GROSSMAN, LLC IS INVESTIGATING AKERO THERAPEUTICS, INC. (AKRO) AND ENCOURAGES INVESTORS TO CONNECT

22-05-2025
NEW YORK CITY, NY / ACCESS NEWSWIRE / MAY 22, 2025 / BRONSTEIN, GEWIRTZ & GROSSMAN, LLC IS INVESTIGA...
Více zde

BRONSTEIN, GEWIRTZ & GROSSMAN, LLC ENCOURAGES AKERO THERAPEUTICS, INC. (AKRO) STOCKHOLDERS TO INQUIRE ABOUT SECURITIES INVESTIGATION

20-05-2025
NEW YORK CITY, NY / ACCESS NEWSWIRE / MAY 20, 2025 / BRONSTEIN, GEWIRTZ & GROSSMAN, LLC IS INVESTIGA...
Více zde

BRONSTEIN, GEWIRTZ & GROSSMAN, LLC INITIATES AN INVESTIGATION INTO ALLEGATIONS AGAINST AKERO THERAPEUTICS, INC. (AKRO) AND ENCOURAGES STOCKHOLDERS TO REACH OUT

18-05-2025
NEW YORK CITY, NY / ACCESS NEWSWIRE / MAY 18, 2025 / BRONSTEIN, GEWIRTZ & GROSSMAN, LLC IS INVESTIGA...
Více zde

BRONSTEIN, GEWIRTZ & GROSSMAN, LLC IS INVESTIGATING AKERO THERAPEUTICS, INC. (AKRO) AND ENCOURAGES STOCKHOLDERS TO CONNECT

15-05-2025
NEW YORK CITY, NY / ACCESS NEWSWIRE / MAY 15, 2025 / BRONSTEIN, GEWIRTZ & GROSSMAN, LLC IS INVESTIGA...
Více zde

AKERO THERAPEUTICS, INC. (AKRO) INVESTIGATION: BRONSTEIN, GEWIRTZ & GROSSMAN, LLC ENCOURAGES STOCKHOLDERS TO CONTACT THE FIRM TO LEARN MORE ABOUT THE INVESTIGATION

13-05-2025
NEW YORK CITY, NY / ACCESS NEWSWIRE / MAY 13, 2025 / BRONSTEIN, GEWIRTZ & GROSSMAN, LLC IS INVESTIGA...
Více zde

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2025-12-09 00:00:008-KStáhnout
2025-12-03 00:00:008-KStáhnout
2025-11-07 00:00:0010-QStáhnout
2025-10-09 01:00:008-KStáhnout
2025-10-09 00:00:008-KStáhnout
2025-09-29 01:00:008-KStáhnout
2025-09-29 00:00:008-KStáhnout
2025-08-08 01:00:008-KStáhnout
2025-08-08 01:00:0010-QStáhnout
2025-08-08 00:00:008-KStáhnout
2025-08-08 00:00:0010-QStáhnout
2025-06-04 01:00:008-KStáhnout
2025-06-04 00:00:008-KStáhnout
2025-05-12 01:00:008-KStáhnout
2025-05-12 01:00:0010-QStáhnout
2025-05-12 00:00:008-KStáhnout
2025-05-12 00:00:0010-QStáhnout
2025-02-28 00:00:008-KStáhnout
2025-02-28 00:00:0010-KStáhnout
2025-02-27 23:00:008-KStáhnout
2025-02-27 23:00:0010-KStáhnout
2025-01-30 00:00:008-KStáhnout
2025-01-29 23:00:008-KStáhnout
2025-01-27 00:00:008-KStáhnout
2025-01-26 23:00:008-KStáhnout
2024-11-08 00:00:008-KStáhnout
2024-11-08 00:00:0010-QStáhnout
2024-11-07 23:00:008-KStáhnout
2024-11-07 23:00:0010-QStáhnout
2024-08-09 01:00:008-KStáhnout
2024-08-09 01:00:0010-QStáhnout
2024-08-09 00:00:008-KStáhnout
2024-08-09 00:00:0010-QStáhnout
2024-06-12 01:00:008-KStáhnout
2024-06-12 00:00:008-KStáhnout
2024-05-10 01:00:008-KStáhnout
2024-05-10 01:00:0010-QStáhnout
2024-05-10 00:00:008-KStáhnout
2024-05-10 00:00:0010-QStáhnout
2024-03-18 00:00:008-KStáhnout
2024-03-17 23:00:008-KStáhnout
2024-03-06 00:00:008-KStáhnout
2024-03-05 23:00:008-KStáhnout
2024-03-04 00:00:008-KStáhnout
2024-03-03 23:00:008-KStáhnout
2024-02-29 00:00:008-KStáhnout
2024-02-29 00:00:0010-KStáhnout
2024-02-28 23:00:008-KStáhnout
2024-02-28 23:00:0010-KStáhnout
2023-12-18 00:00:008-KStáhnout
2023-12-17 23:00:008-KStáhnout
2023-11-13 00:00:008-KStáhnout
2023-11-13 00:00:0010-QStáhnout
2023-11-12 23:00:008-KStáhnout
2023-11-12 23:00:0010-QStáhnout
2023-10-10 01:00:008-KStáhnout
2023-10-10 00:00:008-KStáhnout
2023-08-11 01:00:008-KStáhnout
2023-08-11 01:00:0010-QStáhnout
2023-08-11 00:00:008-KStáhnout
2023-08-11 00:00:0010-QStáhnout
2023-06-26 01:00:008-KStáhnout
2023-06-26 00:00:008-KStáhnout
2023-06-05 01:00:008-KStáhnout
2023-06-05 00:00:008-KStáhnout
2023-05-17 01:00:008-KStáhnout
2023-05-17 00:00:008-KStáhnout
2023-05-15 01:00:008-KStáhnout
2023-05-15 01:00:0010-QStáhnout
2023-05-15 00:00:008-KStáhnout
2023-05-15 00:00:0010-QStáhnout
2023-03-29 01:00:008-KStáhnout
2023-03-29 00:00:008-KStáhnout
2023-03-17 00:00:008-KStáhnout
2023-03-17 00:00:0010-KStáhnout
2023-03-16 23:00:008-KStáhnout
2023-03-16 23:00:0010-KStáhnout
2022-11-04 00:00:008-KStáhnout
2022-11-04 00:00:0010-QStáhnout
2022-11-03 23:00:008-KStáhnout
2022-11-03 23:00:0010-QStáhnout
2022-09-16 01:00:008-KStáhnout
2022-09-16 00:00:008-KStáhnout
2022-09-13 01:00:008-KStáhnout
2022-09-13 00:00:008-KStáhnout
2022-08-05 01:00:0010-QStáhnout
2022-08-05 00:00:0010-QStáhnout
2022-08-04 01:00:008-KStáhnout
2022-08-04 00:00:008-KStáhnout
2022-06-16 01:00:008-KStáhnout
2022-06-16 00:00:008-KStáhnout
2022-06-08 01:00:008-KStáhnout
2022-06-08 00:00:008-KStáhnout
2022-06-03 01:00:008-KStáhnout
2022-06-03 00:00:008-KStáhnout
2022-05-06 01:00:008-KStáhnout
2022-05-06 01:00:0010-QStáhnout
2022-05-06 00:00:008-KStáhnout
2022-05-06 00:00:0010-QStáhnout
2022-02-25 00:00:008-KStáhnout
2022-02-25 00:00:0010-KStáhnout
2022-02-24 23:00:008-KStáhnout
2022-02-24 23:00:0010-KStáhnout
2021-12-10 00:00:008-KStáhnout
2021-12-09 23:00:008-KStáhnout
2021-11-12 00:00:008-KStáhnout
2021-11-12 00:00:0010-QStáhnout
2021-11-11 23:00:008-KStáhnout
2021-11-11 23:00:0010-QStáhnout
2021-09-09 01:00:008-KStáhnout
2021-09-09 00:00:008-KStáhnout
2021-08-13 01:00:008-KStáhnout
2021-08-13 01:00:0010-QStáhnout
2021-08-13 00:00:008-KStáhnout
2021-08-13 00:00:0010-QStáhnout
2021-07-14 01:00:008-KStáhnout
2021-07-14 00:00:008-KStáhnout
2021-06-25 01:00:008-KStáhnout
2021-06-25 00:00:008-KStáhnout
2021-06-21 01:00:008-KStáhnout
2021-06-21 00:00:008-KStáhnout
2021-06-02 01:00:008-KStáhnout
2021-06-02 00:00:008-KStáhnout
2021-05-13 01:00:008-KStáhnout
2021-05-13 01:00:0010-QStáhnout
2021-05-13 00:00:008-KStáhnout
2021-05-13 00:00:0010-QStáhnout
2021-04-26 01:00:008-KStáhnout
2021-04-26 00:00:008-KStáhnout
2021-04-13 01:00:008-KStáhnout
2021-04-13 00:00:008-KStáhnout
2021-03-23 00:00:008-KStáhnout
2021-03-22 23:00:008-KStáhnout
2021-03-22 00:00:008-KStáhnout
2021-03-21 23:00:008-KStáhnout
2021-03-16 00:00:008-KStáhnout
2021-03-16 00:00:0010-KStáhnout
2021-03-15 23:00:008-KStáhnout
2021-03-15 23:00:0010-KStáhnout
2021-03-12 00:00:008-KStáhnout
2021-03-11 23:00:008-KStáhnout
2021-01-11 00:00:008-KStáhnout
2021-01-10 23:00:008-KStáhnout
2020-11-16 00:00:008-KStáhnout
2020-11-15 23:00:008-KStáhnout
2020-11-12 00:00:008-KStáhnout
2020-11-12 00:00:0010-QStáhnout
2020-11-11 23:00:008-KStáhnout
2020-11-11 23:00:0010-QStáhnout
2020-10-15 01:00:008-KStáhnout
2020-10-15 00:00:008-KStáhnout
2020-08-12 01:00:008-KStáhnout
2020-08-12 01:00:0010-QStáhnout
2020-08-12 00:00:008-KStáhnout
2020-08-12 00:00:0010-QStáhnout
2020-06-30 01:00:008-KStáhnout
2020-06-30 00:00:008-KStáhnout
2020-06-17 01:00:008-KStáhnout
2020-06-17 00:00:008-KStáhnout
2020-06-10 01:00:008-KStáhnout
2020-06-10 00:00:008-KStáhnout
2020-06-02 01:00:008-KStáhnout
2020-06-02 00:00:008-KStáhnout
2020-05-28 01:00:008-KStáhnout
2020-05-28 00:00:008-KStáhnout
2020-05-13 01:00:008-KStáhnout
2020-05-13 01:00:0010-QStáhnout
2020-05-13 00:00:008-KStáhnout
2020-05-13 00:00:0010-QStáhnout
2020-03-31 01:00:008-KStáhnout
2020-03-31 00:00:008-KStáhnout
2020-03-16 00:00:008-KStáhnout
2020-03-16 00:00:0010-KStáhnout
2020-03-15 23:00:008-KStáhnout
2020-03-15 23:00:0010-KStáhnout
2020-02-26 00:00:008-KStáhnout
2020-02-25 23:00:008-KStáhnout
2020-01-13 00:00:008-KStáhnout
2020-01-12 23:00:008-KStáhnout
2019-11-12 00:00:008-KStáhnout
2019-11-12 00:00:0010-QStáhnout
2019-11-11 23:00:008-KStáhnout
2019-11-11 23:00:0010-QStáhnout
2019-09-06 01:00:008-KStáhnout
2019-09-06 00:00:008-KStáhnout
2019-08-16 01:00:008-KStáhnout
2019-08-16 00:00:008-KStáhnout
2019-08-12 01:00:008-KStáhnout
2019-08-12 01:00:0010-QStáhnout
2019-08-12 00:00:008-KStáhnout
2019-08-12 00:00:0010-QStáhnout
2019-06-24 01:00:008-KStáhnout
2019-06-24 00:00:008-KStáhnout
preloader